Jiuzhou Pharmaceutical Industry: Obtained European CEP Certificate for Chemical Active Pharmaceutical Ingredients

Jiuzhou Pharmaceutical announced that the company recently received the European Pharmacopoeia conformity assessment certificate for sulfamethoxazole raw materials issued by the European Medicines Agency. According to public data, the market size of sulfamethoxazole in China has reached 4.28 billion RMB, an increase of 3.1% year-on-year.